lindas have a posse
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I added 68K shares today now at 550K total in NWBO. Overweight, an understatement!
Excellent opening opportunity Monday post ASCO. I believe we will be above 0.75 after the Bosch presentation.
Glad to help.
Now at 550K shares.
Linda Liau has a board position at ClearPoint Neuro. I can see her taking a board seat at NWBO as part of a Merck partnership. That would be a natural synergy.
Buying NWBO isn't something one does on a whim.
If shareholders were unhappy they would be selling in large volume. The opposite true. Looks like my order will not fill today.
Trying 69K @ 0.5959.
I don't see any issues. Some simply like to complain.
Bourbon isn't the solution.
Q4 2023 in my opinion seems very realistic for UK approval. It could be sooner.
Adam Feuerstein needs to stop spreading lies.
Nothing has been delayed. There's no approval timeline benchmark against which to compare this personalized autologous cell-based therapy. So when you say X number of GBM patients died, while management are delayed, that isn't factual in any respect. They're not late, delayed, or dealing with some fatal issue that precludes approval.
You have no idea what's going on behind the scenes. From SEC filings and PRs we know that they're working on approval. If negative feedback was given by MHRA, FDA, et al, that would be a mandatory disclosure. In reality the opposite occurred at every step. The notion that management are responsible for the deaths of GBM patients to me seems like absolute lunacy as without their efforts this life-saving treatment wouldn't be, in my opinion, months away from approval.
JAMA, MHRA, FDA, Health Canada, EMA all love DCVax.
More GBM patients died taking Temodar than DCVax. So if you are upset at a management team it should be those who have the financial resources to address the problem. We have the technology and soon the money as well.
Wrong yet again
Hey bro welcome to Northwest Biotherapeutics IHUB forum.
Not filled yet.
Where are the loud mouth swing traders when I need their assistance?
I agree hank. Has Bosch ever had a talk about all solid tumors?
No!
Management are telling us GBM in the bag whereas SEC filings state many times they want to launch more trials.
I believe the 3M payment will be one of many to secure partnership.
Buying 35,000 @ 0.58.
Are you going to write a letter to the CEO of Merck blaming his management team for all of the GBM patients who died taking Temodar?
Anything under $25 is a steal as I believe we will be trading at that price after MHRA approval this year.
He forgets that management own hundreds of millions of shares in this company. They have no desire to debase the value of their holdings. In fact from the most recent loan there was no dilution.
I do not trade. I am adding to reach my goal of 500K shares. I have about 460K now.
The strategy to me seems rather clear. They will own the global Glioblastoma market. That's 100B market cap.
Landmark Trial Results!
JAMA!
MHRA Trial Endorsement (PIP)!
MHRA-endorsed Manufacturing (MIA)!
Global Patent Protection!
My 500K shares should be worth $40M or more once Northwest Biotherapeutics obtains global approval on nGBM and rGBM indications.
I see no reason to sell my shares since I can borrow against them once NWBO are off OTC.
In my personal opinion as a retail investor representing myself alone, and not providing investment advice, longs must focus upon the deep value present in Northwest Biotherapeutics stock!
Billionaire Robert Hefner agrees:
Our Northwest Biotherapeutics (NWBO) investee “partner” likely has just made one of the biggest breakthroughs in the history of cancer. We know that is a really big statement so why do we at GHK believe that is possible? Because we believe the doors through which major cancer breakthroughs must pass are the human immune system, immunotherapies and personalized vaccines and NWBO has just leaped through those doors with its personalized DCVax vaccine made from your own cells.
You can argue about trial statistics until the cows come home but the bottom line is 1) people living longer 2) quality of life during treatments and 3) the cost of treatments.
During NWBO’s 16-year Phase III trial to treat glioblastoma (GBM), one of the most difficult and lethal of all solid tumor cancers 1) more people lived longer, 2) it is safe with virtually no side effects occurring and 3) NWBO estimates treatments will cost about half as much as Standard of Care chemotherapy and radiation treatments. So for the first time ever, GBM patients can have hope! And can hope like prayer increase the effectiveness and energy of the immune system? We think so.
We are aware we stuck our necks out when we said “possibly one of the biggest breakthroughs in the history of cancer”. So we have listed below our three principle reasons so you can decide for yourself:
After 417 failed GBM trials treating 31,952 patents over decades, DCVax-L is first treatment that gives GBM patients a meaningful chance to live longer, some now living 9 to as many as 19 years and counting.
DCVax was conceived and created not for glioblastoma alone but as a personalized tool of your own immune system to defeat all solid tumor cancers and that’s 90% of all cancers.
Since DCVax’s creation NWBO has amassed an enormous rich databank containing masses of information on patients, treatments, and DCVax’s use against 15 different solid tumor cancers that has not yet been analyzed by artificial intelligence (AI). We believe that in the near future when these vast amounts of data and information are teamed with AI and some of the world’s leading scientists and doctors that future generations of DCVax vaccines and protocols will experience great leaps forward in effectiveness at lower and lower costs for 90% of all cancers.
So to sum up, we believe NWBO with its DCVax immunotherapy personalized vaccines has leaped through the doors and will play a vital role in humanities great drive to defeat cancer once and for all.
Dr. Ashkan is the genius behind this viral vid of him performing brain surgery while his patient was awakened to play the violin…mid-surgery. He told me he champions DCVax-L bc of trial data along with what he’s seen first-hand from his patients. $NWBOhttps://t.co/XFTeSPFtH5
— Wade Kovash (@wkovash) June 6, 2022
Watch one of the world’s preeminent neurosurgeons explain the significance of $NWBO ‘s Phase III trial of DCVax-L. The results are groundbreaking and represent an enormous advancement in one of the most tragic cancers. https://t.co/eQw5tAsivK
— Wade Kovash (@wkovash) June 6, 2022
Buying today @ 0.58.
I agree the weak hands should exit now.
According to EDGAR you are wrong as the most recent loans do not have any dilution.
Management control a minority of shares. If you are so unhappy then meet me at 0.601.
None of the recent financings involved dilution.
If you are unhappy then it could be time to sell. Your wife might be happy owning MRK which may benefit from DCVax in a future partnership.
Landmark Trial Results!
MHRA Trial Endorsement (PIP)!
Innovative MHRA-endorsed Manufacturing!
Global Patent Protection!
My 500K shares should be worth $40M or more once Northwest Biotherapeutics obtains global approval on nGBM and rGBM indications.
I see no reason to sell my shares since I can borrow against them once NWBO are off OTC.
In my personal opinion as a retail investor representing myself alone, and not providing investment advice, longs must focus upon the deep value present in Northwest Biotherapeutics stock!
Billionaire Robert Hefner agrees:
Our Northwest Biotherapeutics (NWBO) investee “partner” likely has just made one of the biggest breakthroughs in the history of cancer. We know that is a really big statement so why do we at GHK believe that is possible? Because we believe the doors through which major cancer breakthroughs must pass are the human immune system, immunotherapies and personalized vaccines and NWBO has just leaped through those doors with its personalized DCVax vaccine made from your own cells.
You can argue about trial statistics until the cows come home but the bottom line is 1) people living longer 2) quality of life during treatments and 3) the cost of treatments.
During NWBO’s 16-year Phase III trial to treat glioblastoma (GBM), one of the most difficult and lethal of all solid tumor cancers 1) more people lived longer, 2) it is safe with virtually no side effects occurring and 3) NWBO estimates treatments will cost about half as much as Standard of Care chemotherapy and radiation treatments. So for the first time ever, GBM patients can have hope! And can hope like prayer increase the effectiveness and energy of the immune system? We think so.
We are aware we stuck our necks out when we said “possibly one of the biggest breakthroughs in the history of cancer”. So we have listed below our three principle reasons so you can decide for yourself:
After 417 failed GBM trials treating 31,952 patents over decades, DCVax-L is first treatment that gives GBM patients a meaningful chance to live longer, some now living 9 to as many as 19 years and counting.
DCVax was conceived and created not for glioblastoma alone but as a personalized tool of your own immune system to defeat all solid tumor cancers and that’s 90% of all cancers.
Since DCVax’s creation NWBO has amassed an enormous rich databank containing masses of information on patients, treatments, and DCVax’s use against 15 different solid tumor cancers that has not yet been analyzed by artificial intelligence (AI). We believe that in the near future when these vast amounts of data and information are teamed with AI and some of the world’s leading scientists and doctors that future generations of DCVax vaccines and protocols will experience great leaps forward in effectiveness at lower and lower costs for 90% of all cancers.
So to sum up, we believe NWBO with its DCVax immunotherapy personalized vaccines has leaped through the doors and will play a vital role in humanities great drive to defeat cancer once and for all.
Dr. Ashkan is the genius behind this viral vid of him performing brain surgery while his patient was awakened to play the violin…mid-surgery. He told me he champions DCVax-L bc of trial data along with what he’s seen first-hand from his patients. $NWBOhttps://t.co/XFTeSPFtH5
— Wade Kovash (@wkovash) June 6, 2022
Watch one of the world’s preeminent neurosurgeons explain the significance of $NWBO ‘s Phase III trial of DCVax-L. The results are groundbreaking and represent an enormous advancement in one of the most tragic cancers. https://t.co/eQw5tAsivK
— Wade Kovash (@wkovash) June 6, 2022
I have a buy order open at 0.601. If you hate management so much then sell me your shares.
Management clearly are not going to issue PR for non events or send out statements devoid of substance. Every time a material update goes out what happens? Criminals manipulate their words as well as our share price. So why would they telegraph their daily activities which are not material as this would only provide more fodder for the criminal manipulators?
I have a limit buy order open at 0.601.
I encourage all angry shareholders to sell me their shares.
You're accusing management of fraud. If you think they're criminals then please sell your shares. I am buying today.
Are you selling today? I am buying.
Trillion dollar technology.
Trillion dollar technology
Nobody gives $3M without expecting a return.
Excellence isn't frustrating. It's a process. Those who can't handle it should sell so others can buy.